ARA-290

What it is: An 11-amino-acid peptide derived from erythropoietin — keeps EPO's tissue-protective effects while removing its red-blood-cell-stimulating effects.

What it does: Expect reduced neuropathic pain, improved nerve healing, anti-inflammatory effects, and benefits for sarcoidosis and diabetic neuropathy.

How it's used: Subcutaneous injection 2-3 times per week.